Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

EMTRICITABINE\TENOFOVIR for Hepatitis c: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 14 adverse event reports in the FDA FAERS database where EMTRICITABINE\TENOFOVIR was used for Hepatitis c.

Most Reported Side Effects for EMTRICITABINE\TENOFOVIR

Side Effect Reports % Deaths Hosp.
Foetal exposure during pregnancy 404 13.6% 57 35
Death 205 6.9% 203 10
Maternal exposure during pregnancy 196 6.6% 7 17
Drug ineffective 175 5.9% 1 5
Hiv infection 172 5.8% 3 6
Exposure during pregnancy 164 5.5% 9 21
Abortion spontaneous 141 4.8% 12 13
Virologic failure 129 4.4% 6 3
Neurodevelopmental disorder 80 2.7% 0 0
Nausea 67 2.3% 2 18
No adverse event 62 2.1% 0 2
Immune reconstitution inflammatory syndrome 60 2.0% 3 32
Treatment noncompliance 60 2.0% 1 11
Drug resistance 55 1.9% 0 5
Premature baby 55 1.9% 9 13

Other Indications for EMTRICITABINE\TENOFOVIR

Hiv infection (1,459) Prophylaxis against hiv infection (635) Product used for unknown indication (470) Antiretroviral therapy (131) Maternal exposure timing unspecified (35) Acquired immunodeficiency syndrome (21) Prophylaxis (18) Foetal exposure during pregnancy (17) Hepatitis b (12) Supplementation therapy (8)

Other Drugs Used for Hepatitis c

RIBAVIRIN (20,657) PEGINTERFERON ALFA-2A (10,970) LEDIPASVIR\SOFOSBUVIR (8,924) DASABUVIR\OMBITASVIR\PARITAPREVIR\RITONAVIR (8,264) SOFOSBUVIR (7,691) SOFOSBUVIR\VELPATASVIR (4,956) GLECAPREVIR\PIBRENTASVIR (4,016) OMBITASVIR\PARITAPREVIR\RITONAVIR (2,906) TELAPREVIR (2,604) DASABUVIR (2,603)

Related Pages

EMTRICITABINE\TENOFOVIR Full Profile All Hepatitis c Drugs EMTRICITABINE\TENOFOVIR Demographics EMTRICITABINE\TENOFOVIR Timeline